Annovis Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.About ANVS
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases.
CEOMaria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees8
Employees8
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2008
Founded2008
Employees8
Employees8
ANVS Key Statistics
Market cap34.88M
Market cap34.88M
Price-Earnings ratio-0.81
Price-Earnings ratio-0.81
Dividend yield—
Dividend yield—
Average volume318.16K
Average volume318.16K
High today$1.80
High today$1.80
Low today$1.67
Low today$1.67
Open price$1.67
Open price$1.67
Volume342.57K
Volume342.57K
52 Week high$17.88
52 Week high$17.88
52 Week low$1.11
52 Week low$1.11
People also own
Based on the portfolios of people who own ANVS. This list is generated using Robinhood data, and it’s not a recommendation.